A Randomized, Double-Blind, Placebo-Controlled, Cross-over Study to Evaluate the Effect of the Leukotriene Antagonist (Singulair) Plus Moderate Dose Beclomethasone Compared to High Dose Beclomethasone in Obese Subjects With Moderate Persistent Asthma.
Phase of Trial: Phase IV
Latest Information Update: 03 Jan 2013
At a glance
- Drugs Montelukast (Primary) ; Beclometasone
- Indications Asthma
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 19 Dec 2012 Planned End Date changed from 1 Sep 2011 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 24 Nov 2009 New trial record